1
|
Kim J, Song M, Ahn S, Kwon SL. Twenty Years of Progress and the Way Forward: Immunization Registry Information System in Korea. J Korean Med Sci 2024; 39:e119. [PMID: 38565176 PMCID: PMC10985501 DOI: 10.3346/jkms.2024.39.e119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/11/2023] [Accepted: 03/10/2024] [Indexed: 04/04/2024] Open
Abstract
The National Immunization Program in The Republic of Korea offers mandatory and free vaccinations to children under 12, regulated by the Infectious Disease Prevention and Control Act. Tracking vaccination coverage is crucial for population protection and public health strategies. Since 2002, the Immunization Registry Information System (IRIS) has been used nationwide to capture vaccination data. This study reviewed documents related to IRIS's establishment and development. The Republic of Korea legally supports IRIS's construction and data collection, integrating vaccination data with the Ministry of the Interior and Safety's resident registration to minimize errors. This collaboration also facilitates cost reimbursement and digital registration, promoting wider vaccination coverage. IRIS manages expense claims once vaccination details are logged, and authorized medical institutions can access these records in real-time. Since 2015, the Korea Disease Control and Prevention Agency has been compiling annual data on national vaccination coverage. IRIS also sends automated reminders in 12 languages, reports adverse effects, and issues vaccination certificates. However, IRIS lacks integration between vaccine and disease registries, unlike countries such as England, Denmark, and the Netherlands. Improving integration capabilities could enhance IRIS's support for public health through an integrated information system.
Collapse
Affiliation(s)
- Junghee Kim
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Graduate School of Public Health, Chungnam National University, Daejeon, Korea
| | - Minju Song
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Graduate School of Public Health, Chungnam National University, Daejeon, Korea
| | - Seohyeon Ahn
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
| | - Seunghyun Lewis Kwon
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- KDI School of Public Policy and Management, Sejong, Korea.
| |
Collapse
|
2
|
Cho J, Kim EM, Kim J, Shin JY, Kim EH, Park JH, Kwon SL, Kwon GY, Shin SA, Kim J. Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of South Korean adolescent girls. Epidemiol Health 2024:e2024040. [PMID: 38549356 DOI: 10.4178/epih.e2024040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Accepted: 03/04/2024] [Indexed: 04/17/2024] Open
Abstract
Objectives The purpose of this study was to assess the effectiveness of human papillomavirus (HPV) vaccination administered to adolescent girls through South Korea's National Immunization Program. Methods This retrospective cohort study included individuals who were 12 to 13 years old, whether vaccinated or unvaccinated, between July 2016 and December 2017. The incidence of genital warts (GWs) was monitored through 2021. Time-stratified hazard ratios (HRs) were estimated, adjusting for birth year, socioeconomic status, and the level of urbanization of the region, and were presented with 95% confidence intervals (CIs). Data were sourced from the Immunization Registry Integration System, linked with the National Health Information Database. Results The study included 332,062 adolescent girls, with an average follow-up period of approximately 4.6 years. Except for the first year, the HRs for the vaccinated group were lower than those for the unvaccinated group. The HRs for specific cutoff years were as follows: year 2, 0.62 (95% CI, 0.31 to 1.13); year 3, 0.58 (95% CI, 0.35 to 0.96); and year 4 and beyond, 0.39 (95% CI, 0.28 to 0.52). Conclusion Our findings indicate that HPV vaccination was associated with a reduction in the risk of GWs among adolescent girls. Notably, this reduction became significant as the incidence of GWs increased with age.
Collapse
Affiliation(s)
- Jaeyoung Cho
- Department of Big Data Strategy, National Health Insurance Services, Wonju, Korea
| | - Eun Mi Kim
- Department of Big Data Strategy, National Health Insurance Services, Wonju, Korea
| | - Jihye Kim
- Department of Big Data Strategy, National Health Insurance Services, Wonju, Korea
| | - Ju-Young Shin
- School of Pharmacy, Sungkyunkwan University, Suwon, Korea
| | - Eui Hyeok Kim
- Department of Obstetrics & Gynecology, CHA Ilsan Medical Center, Goyang, Korea
| | - Jong Heon Park
- Department of Big Data Strategy, National Health Insurance Services, Wonju, Korea
| | - Seunghyun Lewis Kwon
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
| | - Geun-Yong Kwon
- Division of Immunization Planning, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
| | - Soon-Ae Shin
- Health Insurance Research Institute, National Health Insurance Services, Wonju, Korea
| | - Jaiyong Kim
- Department of Big Data Strategy, National Health Insurance Services, Wonju, Korea
| |
Collapse
|
3
|
Lee J, Kwon SL, Park J, Bae H, Lee H, Kwon GY. JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study. Osong Public Health Res Perspect 2023; 14:433-438. [PMID: 37920899 PMCID: PMC10626317 DOI: 10.24171/j.phrp.2023.0182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 09/04/2023] [Accepted: 09/08/2023] [Indexed: 11/04/2023] Open
Abstract
BACKGROUND With the recent global mpox outbreak, the JYNNEOS vaccine (Modified Vaccinia Ankara-Bavarian Nordic) was developed as a third-generation smallpox vaccine and initially favored for mpox immunization. Vaccine-associated side effects contribute to vaccine hesitancy. Consequently, tracking adverse events post-immunization is crucial for safety management. This study used data from the national active vaccine safety surveillance conducted in Korea from August 25 to November 24, 2022 to detect potential safety signals and adverse events. METHODS Data on health conditions following vaccination were gathered from web-based surveys and reported via active surveillance through the Immunization Registry Information System. This follow-up system functioned via a text message link, surveying adverse events and health conditions beginning on the second day post-vaccination. Information about specific adverse events, including both local and systemic reactions, was collected. RESULTS The study included 86 healthcare workers who had received at least 1 dose of the JYNNEOS vaccine. Among the respondents, 79.1% reported experiencing at least 1 adverse event, with the majority being local reactions at the injection site. The incidence of adverse events was higher following the first dose (67.9%) than after the second dose (34.4%). The most frequently reported adverse event for both doses was mild pain at the injection site. CONCLUSION The study provides crucial information on the safety of the JYNNEOS vaccine, demonstrating that most adverse events were manageable and predominantly localized to the injection site. Nonetheless, additional research is needed on the safety of various vaccine administration techniques and the vaccine's effects on broader demographics.
Collapse
Affiliation(s)
- Jaeeun Lee
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| | - Seunghyun Lewis Kwon
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
- KDI School of Public Policy and Management, Sejong, Republic of Korea
| | - Jinhee Park
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| | - Hyuna Bae
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| | - Hyerim Lee
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
- Division of Immunization Planning, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| | - Geun-Yong Kwon
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
- Division of Immunization Planning, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| |
Collapse
|
4
|
Kim SJ, Kwon SL, Lee JY, Oh J, Kwon GY. Why school is crucial to increase vaccination coverage for children: Evaluation of school vaccination check program in South Korea 2021-2022. Vaccine 2023; 41:3380-3386. [PMID: 37105889 DOI: 10.1016/j.vaccine.2023.04.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Revised: 04/08/2023] [Accepted: 04/12/2023] [Indexed: 04/29/2023]
Abstract
The School Vaccination Check Program (SVCP) is a public health measure that aims to achieve high levels of National Immunization Program (NIP) vaccination coverage for children by checking the completion of the vaccination schedule for students when they enter elementary or middle school. Due to the COVID-19 pandemic, the SVCP was stopped in 2020 and 2021, and restarted in June-August 2022. In this study, we examined and quantified the relationship with SVCP and the vaccination uptake by comparing the vaccination coverage of 2021 and 2022. Based on the standard schedule, the vaccination records of DTaP5, IPV4, MMR2 and IJEV4 were evaluated for elementary school students. The Tdap6, IJEV5 and HPV1 were evaluated for the students from middle school. Using a difference-in-difference study design and national level big data, the study compared vaccination coverage as of August 2021 and 2022. The study found that the SVCP was effective in increasing vaccination coverage for targeted vaccinations such as DTaP5, IPV4, MMR2 and IJEV4 for elementary school students, and Tdap6, IJEV5 for middle school students. However, the SVCP did not show a statistically significant effect on increasing vaccination coverage on HPV1 for middle school students. School can play an important role to improve vaccination coverage. Therefore, close collaboration with health and education authority is crucial to accomplish successful vaccination program reducing vaccine preventable disease outbreaks in schools.
Collapse
Affiliation(s)
- Seon Ju Kim
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| | - Seunghyun Lewis Kwon
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea; KDI School of Public Policy and Management, Sejong, Republic of Korea.
| | - Jae Young Lee
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| | - Juhwan Oh
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Geun-Yong Kwon
- Division of Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea
| |
Collapse
|
5
|
Kwon SL, Kim BI. How COVID-19 shifted the seasonal flu in Korea. Influenza Other Respir Viruses 2023; 17:e13113. [PMID: 36875206 PMCID: PMC9978056 DOI: 10.1111/irv.13113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Revised: 02/02/2023] [Accepted: 02/03/2023] [Indexed: 03/06/2023] Open
Affiliation(s)
- Seunghyun Lewis Kwon
- Division of Immunization Korea Disease Control and Prevention Agency Cheongju Republic of Korea.,KDI School of Public Policy and Management Sejong Republic of Korea
| | - Bryan Inho Kim
- Division of Infectious Disease Control Korea Disease Control and Prevention Agency Cheongju Republic of Korea
| |
Collapse
|
6
|
Kwon SL, Ban S, Shin J, Bae H, Park H, Kwon GY. Monkeypox Vaccination in the Republic of Korea: Identifying the High-Risk Target Group. J Korean Med Sci 2022; 37:e239. [PMID: 35880509 PMCID: PMC9313979 DOI: 10.3346/jkms.2022.37.e239] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/14/2022] [Accepted: 07/15/2022] [Indexed: 11/26/2022] Open
Abstract
In June 2022, the first monkeypox case was reported as imported into Korea. The general public asked whether they should get vaccinated against monkeypox because of the recent COVID-19 vaccination experience. As of the current monkeypox outbreak situation, a ring vaccination strategy for the high-risk group is more appropriate than the mass population vaccination with smallpox vaccines. Therefore, identifying the proper target group by available vaccines based on the risk and benefit analysis is a key issue of the vaccination program. In addition, the target group should be reviewed by the epidemiological situation of the jurisdiction along with the updated evidence of the monkeypox virus on transmission dynamics, severity, and fatality.
Collapse
Affiliation(s)
- Seunghyun Lewis Kwon
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Korea.
| | - Seonhwa Ban
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Korea
| | - Jeeyeon Shin
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Korea
| | - Hyuna Bae
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Korea
| | - Heeyoun Park
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Korea
| | - Geun-Yong Kwon
- Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Korea
- Central Disease Control Headquarters of Monkeypox, Korea Disease Control and Prevention Agency, Cheongju, Korea
| |
Collapse
|
7
|
Affiliation(s)
| | - Juhwan Oh
- Seoul National University College of Medicine, South Korea
| |
Collapse
|